# Banc of California, Inc.: financial statements, quarterly

BANC · NYSE · CIK 1169770 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/banc.md) · [Financials](/companies/banc/financials.md) · [Filings](/companies/banc/filings.md) · [Insiders](/companies/banc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/banc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.1](/filings/0001628280-24-046683.md) | [8.7 d](/filings/0001628280-26-012946.md) | [9.8](/filings/0001169770-25-000024.md) | [9.1](/filings/0001169770-25-000029.md) | [9.1](/filings/0001628280-25-050892.md) | [9.3 d](/filings/0001628280-26-012946.md) | [10.2](/filings/0001628280-26-032923.md) | [9.3](/filings/0001628280-26-054876.md) | [9.8](/filings/0001628280-25-050892.md) | [9.5 d](/filings/0001628280-26-012946.md) | [10.1](/filings/0001628280-26-032923.md) | [11.9](/filings/0001628280-26-054876.md) |
| Interest expense | $m | [315](/filings/0001628280-24-046683.md) | [316](/filings/0001628280-24-022655.md) | [250](/filings/0001169770-25-000024.md) | [233](/filings/0001628280-24-046683.md) | [215](/filings/0001628280-24-046683.md) | [189](/filings/0001169770-25-000024.md) | [174](/filings/0001169770-25-000024.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(3.2)](/filings/0001628280-24-046683.md) | [(177)](/filings/0001628280-24-022655.md) | [11.5](/filings/0001169770-25-000024.md) | [14.3](/filings/0001169770-25-000029.md) | [2.7](/filings/0001628280-25-050892.md) | [13.2](/filings/0001169770-25-000024.md) | [19.5](/filings/0001628280-26-032923.md) | [19.5](/filings/0001628280-26-054876.md) | [22.7](/filings/0001628280-25-050892.md) | [22.4](/filings/0001628280-26-032923.md) | [23.8](/filings/0001628280-26-054876.md) | [(93.9)](/filings/0001628280-26-054876.md) |
| Net income | $m | [(23.3)](/filings/0001628280-24-046683.md) | [(483)](/filings/0001628280-24-022655.md) | [30.9](/filings/0001628280-25-050892.md) | [30.3](/filings/0001628280-25-050892.md) | [8.8](/filings/0001628280-25-050892.md) | [56.9](/filings/0001169770-25-000024.md) | [53.6](/filings/0001628280-26-054876.md) | [28.4](/filings/0001628280-26-054876.md) | [69.6](/filings/0001628280-25-050892.md) | [77.4](/filings/0001628280-26-032923.md) | [72.0](/filings/0001628280-26-054876.md) | [(241)](/filings/0001628280-26-054876.md) |
| Diluted EPS | $ per share | [(0.42)](/filings/0001628280-24-046683.md) | [(4.55)](/filings/0001628280-24-022655.md) | [0.12](/filings/0001169770-25-000024.md) | [0.12](/filings/0001169770-25-000029.md) | [(0.01)](/filings/0001628280-25-050892.md) | [0.28](/filings/0001169770-25-000024.md) | [0.26](/filings/0001628280-26-032923.md) | [0.12](/filings/0001628280-26-054876.md) | [0.38](/filings/0001628280-25-050892.md) | [0.42](/filings/0001628280-26-032923.md) | [0.39](/filings/0001628280-26-054876.md) | [(1.61)](/filings/0001628280-26-054876.md) |
| Basic EPS | $ per share | [(0.42)](/filings/0001628280-24-046683.md) | [(4.55)](/filings/0001628280-24-022655.md) | [0.12](/filings/0001169770-25-000024.md) | [0.12](/filings/0001169770-25-000029.md) | [(0.01)](/filings/0001628280-25-050892.md) | [0.28](/filings/0001169770-25-000024.md) | [0.26](/filings/0001628280-26-032923.md) | [0.12](/filings/0001628280-26-054876.md) | [0.38](/filings/0001628280-25-050892.md) | [0.43](/filings/0001628280-26-032923.md) | [0.40](/filings/0001628280-26-054876.md) | [(1.61)](/filings/0001628280-26-054876.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001169770-23-000074.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [9.2](/filings/0001169770-23-000074.md) | [38.5](/filings/0001628280-25-009438.md) | [36.1](/filings/0001628280-24-022655.md) | [35.2](/filings/0001628280-24-036507.md) | [33.4](/filings/0001628280-24-046683.md) | [33.5](/filings/0001628280-26-012946.md) | [33.8](/filings/0001169770-25-000024.md) | [34.3](/filings/0001169770-25-000029.md) | [34.0](/filings/0001628280-25-050892.md) | [34.8](/filings/0001628280-26-054876.md) | [34.7](/filings/0001628280-26-032923.md) | [35.0](/filings/0001628280-26-054876.md) |
| Total liabilities | $bn | [8.2](/filings/0001169770-23-000074.md) | [35.1](/filings/0001628280-25-009438.md) | [32.7](/filings/0001628280-24-022655.md) | [31.8](/filings/0001628280-24-036507.md) | [29.9](/filings/0001628280-24-046683.md) | [30.0](/filings/0001628280-26-012946.md) | [30.3](/filings/0001169770-25-000024.md) | [30.8](/filings/0001169770-25-000029.md) | [30.5](/filings/0001628280-25-050892.md) | [31.3](/filings/0001628280-26-054876.md) | [31.2](/filings/0001628280-26-032923.md) | [31.6](/filings/0001628280-26-054876.md) |
| Long-term debt | $bn | not reported | [2.9](/filings/0001628280-25-009438.md) | [2.1](/filings/0001628280-24-022655.md) | [1.4](/filings/0001628280-24-036507.md) | [1.6](/filings/0001628280-24-046683.md) | [1.4](/filings/0001628280-26-012946.md) | [1.7](/filings/0001169770-25-000024.md) | [1.9](/filings/0001169770-25-000029.md) | [2.0](/filings/0001628280-25-050892.md) | [2.1](/filings/0001628280-26-054876.md) | [2.6](/filings/0001628280-26-032923.md) | [2.5](/filings/0001628280-26-054876.md) |
| Shareholders' equity | $bn | [2.4](/filings/0001628280-24-046683.md) | [3.4](/filings/0001628280-26-012946.md) | [3.4](/filings/0001628280-25-050892.md) | [3.4](/filings/0001628280-25-050892.md) | [3.5](/filings/0001628280-25-050892.md) | [3.5](/filings/0001628280-26-054876.md) | [3.5](/filings/0001628280-26-054876.md) | [3.4](/filings/0001628280-26-054876.md) | [3.5](/filings/0001628280-25-050892.md) | [3.5](/filings/0001628280-26-054876.md) | [3.6](/filings/0001628280-26-054876.md) | [3.4](/filings/0001628280-26-054876.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [30.1 d](/filings/0001628280-24-046683.md) | [81.6 d](/filings/0001628280-26-012946.md) | [(88.4)](/filings/0001169770-25-000024.md) | [39.1 d](/filings/0001169770-25-000029.md) | [46.9 d](/filings/0001628280-25-050892.md) | [79.8 d](/filings/0001628280-26-012946.md) | [15.1](/filings/0001628280-26-032923.md) | [62.7 d](/filings/0001628280-26-054876.md) | [75.7 d](/filings/0001628280-25-050892.md) | [102 d](/filings/0001628280-26-012946.md) | [49.0](/filings/0001628280-26-032923.md) | [161 d](/filings/0001628280-26-054876.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001628280-24-046683.md) | [3.1 d](/filings/0001628280-26-012946.md) | [1.9](/filings/0001169770-25-000024.md) | [4.7 d](/filings/0001169770-25-000029.md) | [2.3 d](/filings/0001628280-25-050892.md) | [4.1 d](/filings/0001628280-26-012946.md) | [1.5](/filings/0001628280-26-032923.md) | [1.3 d](/filings/0001628280-26-054876.md) | [0.2 d](/filings/0001628280-25-050892.md) | [17.9 d](/filings/0001628280-26-012946.md) | [3.4](/filings/0001628280-26-032923.md) | [2.6 d](/filings/0001628280-26-054876.md) |
| Dividends paid | $m | [0.8 d](/filings/0001628280-24-046683.md) | [17.5 d](/filings/0001628280-26-012946.md) | [16.7](/filings/0001169770-25-000024.md) | [17.3 d](/filings/0001169770-25-000029.md) | [16.4 d](/filings/0001628280-25-050892.md) | [17.9 d](/filings/0001628280-26-012946.md) | [17.3](/filings/0001628280-26-032923.md) | [16.3 d](/filings/0001628280-26-054876.md) | [16.1 d](/filings/0001628280-25-050892.md) | not reported | [18.8](/filings/0001628280-26-032923.md) | [18.9 d](/filings/0001628280-26-054876.md) |
| Share repurchases | $m | [(0.0) d](/filings/0001169770-23-000074.md) | not reported | [0.0](/filings/0001169770-25-000024.md) | [0.0 d](/filings/0001169770-25-000029.md) | [0.0 d](/filings/0001628280-25-050892.md) | not reported | [38.9](/filings/0001628280-26-032923.md) | [113 d](/filings/0001628280-26-054876.md) | [35.9 d](/filings/0001628280-25-050892.md) | [(188) d](/filings/0001628280-26-012946.md) | [32.3](/filings/0001628280-26-032923.md) | [(0.1) d](/filings/0001628280-26-054876.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2019 (2019-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.9](/filings/0001169770-19-000071.md) | [77.5](/filings/0001628280-24-022655.md) | [77.7](/filings/0001628280-24-036507.md) | [77.9](/filings/0001628280-24-046683.md) | [168](/filings/0001169770-25-000024.md) | [168](/filings/0001169770-25-000029.md) | [169](/filings/0001628280-25-050892.md) | [169](/filings/0001628280-26-032923.md) | [158](/filings/0001628280-26-054876.md) | [159](/filings/0001628280-25-050892.md) | [161](/filings/0001628280-26-032923.md) | [156](/filings/0001628280-26-054876.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 157,950,529 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054876.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.